OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
Torbjörn U.C. Järbe, Brian J. LeMay, Teresa Olszewska, et al.
Pharmacology Biochemistry and Behavior (2008) Vol. 91, Iss. 1, pp. 84-90
Open Access | Times Cited: 38
Torbjörn U.C. Järbe, Brian J. LeMay, Teresa Olszewska, et al.
Pharmacology Biochemistry and Behavior (2008) Vol. 91, Iss. 1, pp. 84-90
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
David R. Janero, Alexandros Makriyannis
Expert Opinion on Emerging Drugs (2009) Vol. 14, Iss. 1, pp. 43-65
Closed Access | Times Cited: 178
David R. Janero, Alexandros Makriyannis
Expert Opinion on Emerging Drugs (2009) Vol. 14, Iss. 1, pp. 43-65
Closed Access | Times Cited: 178
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Evidence that spatial memory deficits following bilateral vestibular deafferentation in rats are probably permanent
Jean Ha Baek, Yiwen Zheng, Cynthia L. Darlington, et al.
Neurobiology of Learning and Memory (2010) Vol. 94, Iss. 3, pp. 402-413
Closed Access | Times Cited: 104
Jean Ha Baek, Yiwen Zheng, Cynthia L. Darlington, et al.
Neurobiology of Learning and Memory (2010) Vol. 94, Iss. 3, pp. 402-413
Closed Access | Times Cited: 104
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
Charles W. Schindler, Godfrey H. Redhi, Kiran Vemuri, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 9, pp. 2283-2293
Open Access | Times Cited: 65
Charles W. Schindler, Godfrey H. Redhi, Kiran Vemuri, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 9, pp. 2283-2293
Open Access | Times Cited: 65
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
Kelly S. Sink, Kristen N. Segovia, Jacquelyn R. Sink, et al.
European Neuropsychopharmacology (2009) Vol. 20, Iss. 2, pp. 112-122
Open Access | Times Cited: 82
Kelly S. Sink, Kristen N. Segovia, Jacquelyn R. Sink, et al.
European Neuropsychopharmacology (2009) Vol. 20, Iss. 2, pp. 112-122
Open Access | Times Cited: 82
CB1 receptor antagonists: new discoveries leading to new perspectives
Eszter Kirilly, Xénia Gonda, György Bagdy
Acta Physiologica (2012) Vol. 205, Iss. 1, pp. 41-60
Closed Access | Times Cited: 64
Eszter Kirilly, Xénia Gonda, György Bagdy
Acta Physiologica (2012) Vol. 205, Iss. 1, pp. 41-60
Closed Access | Times Cited: 64
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
Valéria de Almeida, Fernanda Fiel Peres, Raquel Levin, et al.
Schizophrenia Research (2014) Vol. 153, Iss. 1-3, pp. 150-159
Closed Access | Times Cited: 52
Valéria de Almeida, Fernanda Fiel Peres, Raquel Levin, et al.
Schizophrenia Research (2014) Vol. 153, Iss. 1-3, pp. 150-159
Closed Access | Times Cited: 52
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Eszter Kirilly, Xénia Gonda, György Bagdy
Acta Physiologica (2011) Vol. 205, Iss. 1, pp. 41-60
Closed Access | Times Cited: 57
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xianghu He, Chloe J. Jordan, Kiran Vemuri, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 365-373
Open Access | Times Cited: 46
Xianghu He, Chloe J. Jordan, Kiran Vemuri, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 365-373
Open Access | Times Cited: 46
Interactions Between Alcohol and the Endocannabinoid System
George Kunos
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 4, pp. 790-805
Open Access | Times Cited: 36
George Kunos
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 4, pp. 790-805
Open Access | Times Cited: 36
Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies
Sara Jane Ward, Robert B. Raffa
Obesity (2011) Vol. 19, Iss. 7, pp. 1325-1334
Open Access | Times Cited: 46
Sara Jane Ward, Robert B. Raffa
Obesity (2011) Vol. 19, Iss. 7, pp. 1325-1334
Open Access | Times Cited: 46
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Omar Soler‐Cedeño, Zheng‐Xiong Xi
Cells (2022) Vol. 11, Iss. 20, pp. 3262-3262
Open Access | Times Cited: 16
Omar Soler‐Cedeño, Zheng‐Xiong Xi
Cells (2022) Vol. 11, Iss. 20, pp. 3262-3262
Open Access | Times Cited: 16
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
Omar Soler‐Cedeño, Hannah Alton, Guo‐Hua Bi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1678-1688
Open Access | Times Cited: 3
Omar Soler‐Cedeño, Hannah Alton, Guo‐Hua Bi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1678-1688
Open Access | Times Cited: 3
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: Receptor mechanisms
Sylvina M. Raver, Asaf Keller
Neuropharmacology (2014) Vol. 86, pp. 161-173
Open Access | Times Cited: 34
Sylvina M. Raver, Asaf Keller
Neuropharmacology (2014) Vol. 86, pp. 161-173
Open Access | Times Cited: 34
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence
María Scherma, Liana Fattore, Paola Castelli, et al.
Current Pharmaceutical Design (2014) Vol. 20, Iss. 13, pp. 2089-2099
Closed Access | Times Cited: 34
María Scherma, Liana Fattore, Paola Castelli, et al.
Current Pharmaceutical Design (2014) Vol. 20, Iss. 13, pp. 2089-2099
Closed Access | Times Cited: 34
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action
Joel E. Schlosburg, Scott T. O’Neal, Daniel H. Conrad, et al.
Psychopharmacology (2011) Vol. 216, Iss. 3, pp. 323-331
Open Access | Times Cited: 34
Joel E. Schlosburg, Scott T. O’Neal, Daniel H. Conrad, et al.
Psychopharmacology (2011) Vol. 216, Iss. 3, pp. 323-331
Open Access | Times Cited: 34
Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder
Shani Poleg, Emad Kourieh, Angela Ruban, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Shani Poleg, Emad Kourieh, Angela Ruban, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats
Yiwen Zheng, Lucy Stiles, Emma Hamilton, et al.
Hearing Research (2010) Vol. 268, Iss. 1-2, pp. 145-150
Closed Access | Times Cited: 32
Yiwen Zheng, Lucy Stiles, Emma Hamilton, et al.
Hearing Research (2010) Vol. 268, Iss. 1-2, pp. 145-150
Closed Access | Times Cited: 32
The CB1 Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin
Parichehr Hassanzadeh, Anna Hassanzadeh
Neurochemical Research (2012) Vol. 37, Iss. 5, pp. 1112-1120
Closed Access | Times Cited: 29
Parichehr Hassanzadeh, Anna Hassanzadeh
Neurochemical Research (2012) Vol. 37, Iss. 5, pp. 1112-1120
Closed Access | Times Cited: 29
Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
David R. Janero, Loren Lindsley, Venkata Kiran Vemuri, et al.
Expert Opinion on Drug Discovery (2011) Vol. 6, Iss. 10, pp. 995-1025
Closed Access | Times Cited: 26
David R. Janero, Loren Lindsley, Venkata Kiran Vemuri, et al.
Expert Opinion on Drug Discovery (2011) Vol. 6, Iss. 10, pp. 995-1025
Closed Access | Times Cited: 26
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors
Paola Maccioni, Giancarlo Colombo, Irene Lorrai, et al.
Psychopharmacology (2017) Vol. 234, Iss. 17, pp. 2525-2543
Closed Access | Times Cited: 22
Paola Maccioni, Giancarlo Colombo, Irene Lorrai, et al.
Psychopharmacology (2017) Vol. 234, Iss. 17, pp. 2525-2543
Closed Access | Times Cited: 22
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research
Ewa Galaj, Briana J. Hempel, Allamar Moore, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Ewa Galaj, Briana J. Hempel, Allamar Moore, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Antagonism of ∆9-THC induced behavioral effects by rimonabant: Time course studies in rats
Torbjörn U.C. Järbe, Roger S. Gifford, Alexandros Makriyannis
European Journal of Pharmacology (2010) Vol. 648, Iss. 1-3, pp. 133-138
Open Access | Times Cited: 21
Torbjörn U.C. Järbe, Roger S. Gifford, Alexandros Makriyannis
European Journal of Pharmacology (2010) Vol. 648, Iss. 1-3, pp. 133-138
Open Access | Times Cited: 21
